← 返回

研究免疫细胞与结直肠癌风险之间的因果关系:双向和多变量孟德尔随机化分析

英文原题:Investigating the causal relationship between immune cells and colorectal cancer risk using bidirectional and multivariable Mendelian randomization analysis.

查看英文原题

Investigating the causal relationship between immune cells and colorectal cancer risk using bidirectional and multivariable Mendelian randomization analysis.

PubMed 2025/04/26(内容时间) J Recept Signal Transduct Res Q4 · IF 1.9(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

这些发现凸显了特定免疫细胞在 CRC 发病机制中的作用,提示了免疫靶向治疗和 CRC 预防的潜在途径。鉴于全球 CRC 发病率不断上升,了解免疫细胞的作用对于推进有效治疗至关重要。

研究思路结论见上方概要

本研究采用双向孟德尔随机化方法探讨免疫识别多样性与结直肠癌(CRC)风险之间的关系。

对731种免疫细胞类型的遗传数据进行了分析,数据来源于IEU和FinnGen数据库,CRC数据来自芬兰人群的全基因组关联研究。进行了正向和反向孟德尔随机化分析,并通过敏感性分析评估多效性效应。

分析显示,效应记忆CD4和CD8 T细胞增多与CRC风险升高显著相关(OR = 1.11,95% CI = 1.04-1.18,p = .0008)。相反,自然杀伤T细胞上CD45升高与CRC风险降低相关(OR = 0.93,95% CI = 0.88-0.98,p = .0095),表明具有保护作用。敏感性分析证实不存在多效性效应。

展开英文摘要原文

This study explores the relationship between immune recognition diversity and colorectal cancer (CRC) risk using a bidirectional Mendelian randomization approach.

Genetic data from 731 immune cell types were analyzed, with data sourced from the IEU and FinnGen databases and CRC data from genome-wide association studies on the Finnish population. Forward and reverse Mendelian randomization analyses were conducted, with sensitivity analyses to assess pleiotropic effects.

Analyses revealed a significant association between increased Effector Memory CD4 and CD8 T cells and higher CRC risk (odds ratio [OR] = 1.11, 95% confidence interval [CI] = 1.04-1.18, p = .0008). Conversely, elevated CD45 on natural killer T cells was associated with a lower CRC risk (OR = 0.93, 95% CI = 0.88-0.98, p = .0095), indicating a protective effect. Sensitivity analyses confirmed no pleiotropic effects.

These findings highlight specific immune cells' roles in CRC pathogenesis, suggesting potential avenues for immune-targeted therapies and CRC prevention. Given the rising global incidence of CRC, understanding immune cell roles is crucial for advancing effective treatments.

论文信息

作者
Zhou J、Liu Y
单位
Department of General Surgery, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu, China.China
期刊
Journal of receptor and signal transduction research2025 Jun
原文标识
PubMed 40285728 · DOI 10.1080/10799893.2025.2491068